| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |